|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"wu js"
Showing items 81-105 of 149 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2013-05 |
Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors
|
Peng, YH;Shiao, HY;Tu, CH;Liu, PM;Hsu, JT;Amancha, PK;Wu, JS;Coumar, MS;Chen, CH;Wang, SY;Lin, WH;Sun, HY;Chao, YS;Lyu, PC;Hsieh, HP;Wu, SY |
| 臺北醫學大學 |
2013 |
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo
|
Lee, HY;Pan, SL;Su, MC;Liu, YM;Kuo, CC;Chang, YT;Wu, JS;Nien, CY;Mehndiratta, S;Chang, CY;Wu, SY;Lai, MJ;JY*, Chang;JP*, Liou |
| 國立成功大學 |
2012-11 |
How Does Change in Depressive Symptomatology Influence Trajectories in Weight, Behaviors and Cognitive Function in Adults with Diabetes?
|
Chiu, Ching-Ju; Lu, Feng-Hwa; Yang, YC; Wu, JS; Lee, Siao-Ling; Linda A. Wray; Elizabeth A. Beverly |
| 國家衛生研究院 |
2012-05 |
The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study
|
Tai, TY;Tsai, KS;Tu, ST;Wu, JS;Chang, CI;Chen, CL;Shaw, NS;Peng, HY;Wang, SY;Wu, CH |
| 國家衛生研究院 |
2011-11 |
Integration of CNS survival and differentiation by HIF2alpha
|
Ko, CY;Tsai, MY;Tseng, WF;Cheng, CH;Huang, CR;Wu, JS;Chung, HY;Hsieh, CS;Sun, CK;Hwang, SPL;Yuh, CH;Huang, CJ;Pai, TW;Tzou, WS;Hu, CH |
| 國家衛生研究院 |
2011-09 |
Synthesis and biological evaluation of 1-(4′-Indolyl and 6′-Quinolinyl) indoles as a new class of potent anticancer agents
|
Lai, MJ;Chang, JY;Lee, HY;Kuo, CC;Lin, MH;Hsieh, HP;Chang, CY;Wu, JS;Wu, SY;Shey, KS;Liou, JP |
| 國家衛生研究院 |
2011-04-28 |
Scaffold-hopping strategy: Synthesis and biological evaluation of 5,6-Fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents
|
Tung, YS;Coumar, MS;Wu, YS;Shiao, HY;Chang, JY;Liou, JP;Shukla, P;Chang, CW;Chang, CY;Kuo, CC;Yeh, TK;Lin, CY;Wu, JS;Wu, SY;Liao, CC;Hsieh, HP |
| 臺北醫學大學 |
2011 |
Synthesis and Biological Evaluation of 1-(4’-Indolyl and 6’-Quinolinyl)indoles as a New Class of Potent Anticancer Agents
|
Lia, MJ;Chang, JY;Lee, HY;Kuo, CC;Lin, MH;Hsieh, HP;Chang, CY;Wu, JS;Wu, SY;Shey, KS;Liou, JP |
| 臺北醫學大學 |
2011 |
Synthesis and biological evaluation of 1-(40-Indolyl and 60-Quinolinyl) indoles as a new class of potent anticancer agents.
|
Lai, MJ;Chang, JY;Lee, HY;Kuo, CC;Lin, MH;Hsieh, HP;Chang, CY;Wu, JS;Wu, SY;Shey;KS;Liou, JP |
| 國立臺灣海洋大學 |
2011 |
Integration of CNS survival and differentiation by HIF2α
|
Ko CY;Tsai MY;Tseng WF;Cheng CH;Huang CR;Wu JS;Chung HY;Hsieh CS;Sun CK;Hwang SP;Yuh CH;Huang CJ;Pai TW;Tzou WS;Hu CH. |
| 國家衛生研究院 |
2010-12 |
Discovery of non-glycoside sodium-dependent glucose Co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening
|
Wu, JS;Peng, YH;Wu, JM;Hsieh, CJ;Wu, SH;Coumar, MS;Song, JS;Lee, JC;Tsai, CH;Chen, CT;Liu, YW;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2010-10 |
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists
|
Peng, YH;Coumar, MS;Leou, JS;Wu, JS;Shiao, HY;Lin, CH;Lin, WH;Lien, TW;Chen, X;Hsu, JT;Chao, YS;Huang, CF;Lyu, PC;Hsieh, HP;Wu, SY |
| 國家衛生研究院 |
2010-09 |
Cancer cells acquire mitotic drug resistance properties through beta i-tubulin mutations and alterations in the expression of beta-tubulin isotypes
|
Cheung, CHA;Wu, SY;Lee, TR;Chang, CY;Wu, JS;Hsieh, HP;Chang, JY |
| 美和科技大學 |
2010-09 |
Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement
|
Lee RJ;Wu JS;Juang RH;Wu YJ;Lin CY;Wu SY;Huang PR;Chu CH;Chin LT;Chen HM |
| 國家衛生研究院 |
2010-06-15 |
Fast-forwarding hit to lead: Aurora and epidermal growth factor receptor kinase inhibitor lead identification
|
Coumar, MS;Chu, CY;Lin, CW;Shiao, HY;Ho, YL;Reddy, R;Lin, WH;Chen, CH;Peng, YH;Leou, JS;Lien, TW;Huang, CT;Fang, MY;Wu, SH;Wu, JS;Chittimalla, SK;Song, JS;Hsu, JT;Wu, SY;Liao, CC;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2010-03-11 |
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
|
Nien, CY;Chen, YC;Kuo, CC;Hsieh, HP;Chang, CY;Wu, JS;Wu, SY;Liou, JP;Chang, JY |
| 國家衛生研究院 |
2010-02-01 |
Identification, SAR studies, and X-ray Co-crystallographic analysis of a novel furanopyrimidine aurora kinase a inhibitor
|
Coumar, MS;Tsai, MT;Chu, CY;Uang, BJ;Lin, WH;Chang, CY;Chang, TY;Leou, JS;Teng, CH;Wu, JS;Fang, MY;Chen, CH;Hsu, JTA;Wu, SY;Chao, YS;Hsieh, HP |
| 臺北醫學大學 |
2010 |
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
|
Nien, CY;Chen, YC;Kuo, CC;Hsieh, HP;Chang, CY;Wu, JS;Wu, SY;Liou, JP;Chang, JY |
| 國家衛生研究院 |
2009-07-23 |
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity
|
Chiang, YK;Kuo, CC;Wu, YS;Chen, CT;Coumar, MS;Wu, JS;Hsieh, HP;Chang, CY;Jseng, HY;Wu, MH;Leou, JS;Song, JS;Chang, JY;Lyu, PC;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2009-07 |
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins
|
Wu, JS;Lin, TN;Wu, KK |
| 國立臺灣大學 |
2009-06 |
Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.
|
Lin, YC; Tsai, CH; Wu, JS; Huang, CS; Kuo, SH; Lin, CW; Cheng, AL.Leuk |
| 國家衛生研究院 |
2009-04-23 |
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists
|
Lin, CH;Peng, YH;Coumar, MS;Chittimalla, SK;Liao, CC;Lyn, PC;Huang, CC;Lien, TW;Lin, WH;Hsu, JT;Cheng, JH;Chen, X;Wu, JS;Chao, YS;Lee, HJ;Juo, CG;Wu, SY;Hsieh, HP |
| 國家衛生研究院 |
2009-03-03 |
Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation
|
Wu, JS;Cheung, WM;Tsai, YS;Chen, YT;Fong, WH;Tsai, HD;Chen, YC;Liou, JY;Shyue, SK;Chen, JJ;Chen, YE;Maeda, N;Wu, KK;Lin, TN |
| 國家衛生研究院 |
2009-02-26 |
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity
|
Coumar, MS;Leou, JS;Shukla, P;Wu, JS;Dixit, AK;Lin, WH;Chang, CY;Lien, TW;Tan, UK;Chen, CH;Hsu, JTA;Chao, YS;Wu, SY;Hsieh, HP |
| 義守大學 |
2009-01 |
Parallel Molecular Dynamics Simulation of Head-on Collision of Two Nanoscale Droplets with Low Relative Speed
|
Juang RR; Lee YM; Chiang CH;Wu JS;Hsu YL;Chau SW |
Showing items 81-105 of 149 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
|
